Literature DB >> 32650087

Remplissage for anterior shoulder instability with Hill-Sachs lesions: a systematic review and meta-analysis.

Eoghan T Hurley1, James P Toale2, Martin S Davey2, Christopher A Colasanti3, Leo Pauzenberger4, Eric J Strauss3, Hannan Mullett4.   

Abstract

BACKGROUND: The purpose of this study was to perform a systematic review and meta-analysis of the current evidence in the literature to determine how arthroscopic Bankart repair (ABR) and remplissage compare with ABR alone and the open Latarjet procedure for anterior shoulder instability in patients with concomitant Hill-Sachs lesions.
METHODS: A literature search was performed based on the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) guidelines. Studies comparing ABR and remplissage vs. ABR alone or the Latarjet procedure for anterior shoulder instability in patients with Hill-Sachs lesions were included. Clinical outcomes were compared, with all statistical analysis performed using Review Manager (version 5.3). P < .05 was considered statistically significant.
RESULTS: Twelve clinical trials were included. There was a significant difference between ABR plus remplissage and ABR alone in total recurrence rate (3.2% vs. 16.8%, P < .05) but not the rate of revision due to recurrence (1.7% vs. 8.5%, P = .06). There was no significant difference between the Latarjet procedure and ABR plus remplissage in total recurrence rate (7.0% vs. 9.8%, P = .39), total revision rate (3.7% vs. 5.7%, P = .41), and rate of revision due to recurrence (1.6% vs. 2.1%, P = .79). There was a significantly lower rate of complications with ABR and remplissage compared with the Latarjet procedure (0.5% vs. 8.6%, P = .003).
CONCLUSION: In patients with Hill-Sachs lesions and subcritical glenoid bone loss, ABR with remplissage resulted in lower rates of recurrent instability compared with ABR alone while resulting in similar recurrence rates, as well as similar patient-reported outcomes, with lower morbidity and fewer complications, compared with the Latarjet procedure. LEVEL OF EVIDENCE: Level III; Systematic Review.
Copyright © 2020 Journal of Shoulder and Elbow Surgery Board of Trustees. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bankart; Latarjet; anterior shoulder instability; arthroscopy; remplissage; systematic review

Mesh:

Year:  2020        PMID: 32650087     DOI: 10.1016/j.jse.2020.06.021

Source DB:  PubMed          Journal:  J Shoulder Elbow Surg        ISSN: 1058-2746            Impact factor:   3.019


  5 in total

1.  No Difference in Outcomes After Arthroscopic Bankart Repair With Remplissage or Arthroscopic Latarjet Procedure for Anterior Shoulder Instability.

Authors:  Eoghan T Hurley; Christopher A Colasanti; Nathan A Lorentz; Bogdan A Matache; Kirk A Campbell; Laith M Jazrawi; Robert J Meislin
Journal:  Arthrosc Sports Med Rehabil       Date:  2022-04-18

2.  Arthroscopic Bankart and Remplissage for Anteroinferior Instability With Subcritical Bone Loss Has a Low Recurrence Rate.

Authors:  Shirish Pathak; Murtaza J Haidermota; Vimal Kumar K H; Parag Sancheti
Journal:  Arthrosc Sports Med Rehabil       Date:  2022-02-01

3.  Long-term results of arthroscopic Bankart repair with Hill-Sachs remplissage.

Authors:  Alexis Brejuin; Mathieu Girard; Hugo Barret; Vincent Martinel; Pierre Mansat; Nicolas Bonnevialle
Journal:  JSES Int       Date:  2022-07-05

4.  Consideration May Be Given to Lowering the Threshold for the Addition of Remplissage in Patients With Subcritical Glenoid Bone Loss Undergoing Arthroscopic Bankart Repair.

Authors:  Jeffrey L Horinek; Mariano E Menendez; Jonathan J Callegari; Pablo Narbona; Alexandre Lädermann; Johannes Barth; Patrick J Denard
Journal:  Arthrosc Sports Med Rehabil       Date:  2022-06-04

5.  Dynamic and Static Stabilization of Anterior Shoulder Instability With the Subscapular Sling Procedure.

Authors:  Jan Arild Klungsøyr; Terje Vagstad; Peter Johannes Klungsøyr; Alf Inge Hellevik; Jon Olav Drogset
Journal:  Arthrosc Tech       Date:  2021-06-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.